bpc 157 gastroparesis Stable Gastric Pentadecapeptide as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System inflamed GLP-RT Quantity:20mg Cyanocobalamin Injection, 2mg/mL |

bpc 157 gastroparesis Stable Gastric Pentadecapeptide as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System inflamed GLP-RT Quantity:20mg Cyanocobalamin Injection, 2mg/mL |

Cyanocobalamin Injection, 2mg/mL | Olympia Pharmaceuticals

But allowing the peptides—which include BPC-157 and TB-500—to be compounded isn’t the same as approving them as drugs

inflamed

GLP-RT Quantity:20mg

Reported effects Supports tissue repair in gut, tendon, muscle, and skin injury models (animal studies) Exhibits anti-inflammatory and cytoprotective effects in preclinical settings Reported good tolerability in Phase I safety studies without serious adverse events Reported side effects Occasional mild injection-site reactions (redness, itching) Long-term human safety and efficacy are still being investigated Storage Lyophilised (unmixed) Store at -20 °C (-4 °F) in dry, dark conditions